2021-02-15T18:45:09-06:00 2020-03-31 KPMG LLP 345 Park Avenue New York NY 101540102 990 2019-04-01 131949477 New York Blood Center Inc % JOSEPH S MOHR NEWY 2125703100 310 East 67th Street New York NY 10065 JOSEPH S MOHR CFO 2125703016 2021-02-15 true PHILLIP GROFF P01247783 2127589700 2021-02-15 2019 2022-09-23 18:48:47Z Dr Christopher Hillyer 310 East 67th Street New York NY 10065 592942264 false X nybloodcenter.org X 1959 NY AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NYBC OPERATES UNDER A FOUR PART MISSION. FOR MORE INFORMATION, SEE SCH. O AND PART III, 4A-C. 19 18 1749 730 1808926 13590606 13809977 346596532 437376620 30382930 31435059 627078 902157 391197146 483523813 118751 94681 0 0 137296283 178275431 0 0 216515 250504682 304464849 387919716 482834961 3277430 688852 553444220 515795702 78703573 91488744 474740647 424306958 X AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NYBC OPERATES UNDER A FOUR-PART MISSION. FOR MORE INFORMATION, SEE SCH. O AND PART III, 4A-C. false false 256144587 94681 268665735 BLOOD SERVICES: THE COLLECTION AND PROCESSING OF BLOOD PRODUCTS, TESTING OF BLOOD SAMPLES AND THE DISTRIBUTION OF THESE PRODUCTS TO HOSPITALS IN THE GREATER NY AREA FOR TRANSFUSIONS TO PATIENTS. 159283460 168491586 MEDICAL PROGRAMS: PROGRAMS INCLUDE (1) CLINICAL SERVICES (INCLUDING TRANSFUSION THERAPY SERVICES); (2) BONE MARROW PROGRAM; AND (3) HEMOPHILIA SERVICES CONSORTIUM. NATIONAL CORD BLOOD PROGRAM: THE COLLECTION, PROCESSING AND STORAGE OF CORD BLOOD UNITS AND THE DISTRIBUTION OF THESE UNITS FOR TREATMENT OR FOR RESEARCH PURPOSES. 21910333 219299 RESEARCH PROGRAM: THE NEW YORK BLOOD CENTER OPERATES A WIDE-RANGING PROGRAM OF RESEARCH INTO THE PROPERTIES OF BLOOD AND BLOOD RELATED DISEASES. 437338380 true true false true false false false false false false true true false false true true true false false false true false false false false false false true true true true false false false false false false false false false false false false false false false true true true false false true 247 0 true 1749 true true true false false false false false false false false false true false X 19 18 true false true false false false false true true false false true true true true true true true true false CT DE MN NJ NY OK RI WI X JOSEPH S MOHR 2125703016 310 EAST 67TH STREET NEW YORK NY 10065 CHRISTOPHER HILLYER M PRESIDENT & CEO 50.0 0.0 X X 1720790 0 101464 ELIZABETH MCQUAIL EVP - OPS & Manufacturing/COO 50.0 0.0 X 728148 0 89360 C ELIZABETH GIBSON CFO (04/1/2019-07/23/2019) 50.0 0.0 X 703558 0 35086 BETH SHAZ MD EVP, CHIEF MED & SCIENTIFC OFR 50.0 0.0 X 636163 0 52592 JORDANA G SCHWARTZ SVP - Gen Counsel/Secretary 50.0 0.0 X 465800 0 62301 BETSY JETT SVP, QUAL & REGULATORY AFFAIRS 50.0 0.0 X 436297 0 39349 ROBERT PURVIS VP - CUSTOMER SERVICE 50.0 0.0 X 391526 0 57955 PABLO RUBINSTEIN VP - NCBP 50.0 0.0 X 379269 0 39921 MOHANDAS NARLA VP - LFRKI 50.0 0.0 X 373247 0 41406 BRUCE SACHAIS EXECUTIVE MEDICAL DIRECTOR 50.0 0.0 X 349384 0 51661 CONNIE WESTHOFF DIR - IMMUNOHEMATOLOGY 50.0 0.0 X 340032 0 40579 DONNA STRAUSS VP - ENTERPRISE LAB SERVICE 50.0 0.0 X 318020 0 46555 PATRICIA KILLEEN VP-ENT BLOOD OPS OPTIMIZATION 50.0 0.0 X 305931 0 42734 JOON MOON INTERIM CFO (START 09/24/2019) 50.0 0.0 X 283271 0 61161 DAVID GRAHAM Executive Director - CBCKC 50.0 0.0 X 291439 0 50611 BERNADETTE TISO DEPUTY GENERAL COUNSEL 50.0 0.0 X 237810 0 49380 MONIQUE BROWN GEORGE VP - HUMAN RESOURCES 50.0 0.0 X 212090 0 29243 ANDREW MINKOW INT CFO (07/23/19-09/23/2019) 50.0 0.0 X 199633 0 37413 MICHELE SCAGGIANTE VP - CHIEF INFORMATION OFFICER 50.0 0.0 X 179366 0 30487 PHILIP FALIVENE TRUSTEE 1.0 0.0 X 0 0 0 THOMAS HEANEY TRUSTEE (END 3/30/2020) 1.0 0.0 X 0 0 0 MARK SCHMIDTLEIN VICE CHAIR 1.0 0.0 X 0 0 0 ROBERT A SCHWARTZ TRUSTEE 1.0 0.0 X 0 0 0 MARC KRAMER CHAIR, BOARD OF TRUSTEES 1.0 0.0 X 0 0 0 DAVID TENDLER TRUSTEE 1.0 0.0 X 0 0 0 STEPHEN D WURTZLER TRUSTEE 1.0 0.0 X 0 0 0 PAUL M TORGERSON TRUSTEE 1.0 0.0 X 0 0 0 JENNIFER JONES-AUSTIN TRUSTEE (END 07/25/2019) 1.0 0.0 X 0 0 0 AARON R MARCU TRUSTEE 1.0 0.0 X 0 0 0 DAVID DRISCOLL TRUSTEE 1.0 0.0 X 0 0 0 JOHN FERRETTI TRUSTEE 1.0 0.0 X 0 0 0 ARIEL FISHMAN TRUSTEE 1.0 0.0 X 0 0 0 CLAIRE POMEROY TRUSTEE (END 04/18/2019) 1.0 0.0 X 0 0 0 THERESA RAGOZINE TRUSTEE 1.0 0.0 X 0 0 0 CHARLES REPPUCCI TRUSTEE 1.0 0.0 X 0 0 0 JOHN ROSENTHAL TRUSTEE 1.0 0.0 X 0 0 0 MARK SHAW TRUSTEE (END 08/01/2019) 1.0 0.0 X 0 0 0 FAYE WATTLETON TRUSTEE 1.0 0.0 X 0 0 0 OWEN GARRICK TRUSTEE 1.0 0.0 X 0 0 0 AVERY AUGUST TRUSTEE 1.0 0.0 X 0 0 0 PETER LOPEZ TRUSTEE 1.0 0.0 X 0 0 0 8551774 0 959258 201 false true false ATOS IT SOLUTIONS AND SERVICE PO BOX 710878 COLUMBUS OH 43271 IT SERVICES 2544832 INCEPT 4150 BELDEN VILLAGE STREET CANTON OH 44718 DONOR MARKETING 2002449 ALL SYSTEMS MESSENGER 3391 MERRICK ROAD WANTAGH NY 11793 MESSENGER 1506579 CENTURY PROTECTIVE SERVICES 150 GRAND STREET WHITE PLAINS NY 10601 SECURITY 1279379 CROSSROADS COURIER 2008 ALTOM CT SAINT LOUS MO 63146 MESSENGER 1271970 71 12252937 1557040 9120 13809977 BLOOD SERVICES 621500 268665735 268665735 MEDICAL PROGRAMS 621500 168491586 168491586 RESEARCH PROGRAM 621500 219299 219299 437376620 7389858 1808926 5580932 0 4326 4326 897831 897831 0 897831 897831 132675000 788652 108584927 833524 24090073 -44872 24045201 24045201 0 0 0 0 0 0 0 0 0 0 483523813 437376620 1808926 30528290 25000 25000 69681 69681 0 0 7135115 863481 6271634 0 127129257 115978109 11074360 76788 4523904 3652325 866171 5408 23653347 20717434 2920773 15140 15833808 14411558 1415510 6740 1400808 1400808 1797239 233772 1563467 427462 427462 511873 511873 0 1494687 1494687 1604215 655499 845727 102989 545885 445435 100450 2501713 2280610 221103 3075736 3075736 0 5164308 5066719 97589 207190 146483 60707 0 129985 129985 1054582 1054582 0 12113947 9000249 3113607 91 2563850 2025672 538178 SUPPLIES 206676890 205887095 788496 1299 TESTING FEES 27817678 27817678 MGMT FEE-HEMOPHILIA CONSORTIUM 11089144 11089144 REPAIRS AND MAINTENANCE 9892397 8227181 1665216 14395260 7048815 7338385 8060 482834961 437338380 45280066 216515 14654899 36005288 31696189 29945985 0 0 50490933 64019134 0 0 0 0 0 0 36199935 37068955 3287616 5048386 286861524 187680594 52936077 99180930 232009421 1444955 38698518 241137713 91418230 0 0 19190 2052402 1925166 553444220 515795702 59253956 62552947 0 0 6204801 8716419 0 7203548 0 0 0 0 10870772 8998154 0 0 2374044 4017676 78703573 91488744 X 473907647 423775410 833000 531548 474740647 424306958 553444220 515795702 X 688852 -53145799 2023258 X false true X true true true X 14044399 12829969 12883405 13590606 13809977 67158356 312108036 319980728 321238027 346596532 437376620 1737299943 0 0 0 326152435 332810697 334121432 360187138 451186597 1804458299 490440 777863 138183 104344 120000 1630830 0 490440 777863 138183 104344 120000 1630830 1802827469 8777204 8457352 8505075 11907059 6483089 44129779 0 8777204 8457352 8505075 11907059 6483089 44129779 0 0 334929639 341268049 342626507 372094197 457669686 1848588078 0.97525 0.97140 0.02387 0.02770 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 511873 511873 482323087 482834960 1000000 250000 1000000 1000000 1000000 1000000 4000000 6000000 192212 178101 197900 511873 1080086 250000 250000 250000 250000 1000000 1500000 17121175 17121175 115655997 64351809 51304188 0 0 0 96042292 71421535 24620757 58042060 51907250 6134810 99180930 HEDGE FUNDS 2250837 F PRIVATE EQUITY FUNDS 238886876 F 241137713 0 RESERVE FOR CLAIMS 1000000 FMV OF INTEREST RATE SWAP 1533516 OTHER LIABILITIES 1484160 4017676 X 482972238 -53145799 150949 52443275 -551575 483523813 483523813 533405927 150949 50420017 50570966 482834961 482834961 UNCERTAIN TAX POSITIONS SCHEDULE D, PART X, LINE 2 THE ORGANIZATION HAS BEEN DETERMINED BY THE INTERNAL REVENUE SERVICE TO BE A NOT-FOR-PROFIT CORPORATION, EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). AS A NOT-FOR-PROFIT CORPORATION, NYBC IS ALSO EXEMPT FROM STATE AND LOCAL INCOME TAXES. THE ORGANIZATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO THE ORGANIZATION'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. THE ORGANIZATION DID NOT RECOGNIZE ANY UNRELATED BUSINESS INCOME TAX LIABILITY FOR THE YEARS ENDED MARCH 31, 2020 AND 2019. SCHEDULE D, PART XI, LINE 2D Unrealized gain (loss) on SWAP Agreement $(159,472) STUB-period REVENUE of acquired subsidiaries $52,602,747 ---------- TOTAL $52,443,275 FORM 990, SCHEDULE D, PART XII, LINE 2D STUB-PERIOD EXPENSES OF ACQUIRED SUBSIDIARIES $50,420,017 Central America and the Caribbean Investments 595966 Central America and the Caribbean Investments 2396825 2992791 2992791 true false true true true false true AABB NBF 8101 Glenbrook Rd Bethesda MD 20814 362384118 501(c)(3) 25000 GENERAL SUPPORT 1 COLLEGE SCHOLARSHIPS 138 69681 PART I, LINE 2 NYBC HAS PROVIDED FINANCIAL ASSISTANCE, RATHER THAN GRANTS, TO THE ORGANIZATIONS LISTED IN PART I. THIS ASSISTANCE IS CONSISTENT WITH NYBC'S CHARITABLE MISSION. PART III, LINE 1 COLLEGE SCHOLARSHIPS AWARDED TO STUDENTS WHO VOLUNTEER THEIR TIME AT BLOOD DRIVES IN THE FURTHERANCE OF NYBC'S MISSION. X X X X X true true false false false false false true false CHRISTOPHER HILLYER MD PRESIDENT & CEO 1042440 0 600000 0 78350 0 68250 0 33214 0 1822254 0 47950 0 C ELIZABETH GIBSON CFO (04/1/2019-07/23/2019) 299630 0 46662 0 357266 0 19600 0 15486 0 738644 0 9296 0 ANDREW MINKOW INT CFO (07/23/19-09/23/2019) 187899 0 11588 0 146 0 13716 0 23697 0 237046 0 0 0 JOON MOON INTERIM CFO (START 09/24/2019) 270405 0 12866 0 0 0 28000 0 33161 0 344432 0 0 0 BETH SHAZ MD EVP, CHIEF MED & SCIENTIFC OFR 545113 0 56100 0 34950 0 19600 0 32992 0 688755 0 16450 0 ELIZABETH MCQUAIL EVP - OPS & Manufacturing/COO 634387 0 56100 0 37661 0 64853 0 24506 0 817507 0 18661 0 BETSY JETT SVP, QUAL & REGULATORY AFFAIRS 391847 0 38500 0 5950 0 27416 0 11933 0 475646 0 5950 0 JORDANA G SCHWARTZ SVP - Gen Counsel/Secretary 416948 0 41662 0 7190 0 29668 0 32633 0 528101 0 7190 0 PABLO RUBINSTEIN VP - NCBP 379269 0 0 0 0 0 28000 0 11921 0 419190 0 0 0 MOHANDAS NARLA VP - LFRKI 373247 0 0 0 0 0 19600 0 21806 0 414653 0 0 0 ROBERT PURVIS VP - CUSTOMER SERVICE 334183 0 35343 0 22000 0 25168 0 32787 0 449481 0 3500 0 MICHELE SCAGGIANTE VP - CHIEF INFORMATION OFFICER 156121 0 23245 0 0 0 10998 0 19489 0 209853 0 0 0 CONNIE WESTHOFF DIR - IMMUNOHEMATOLOGY 324202 0 15830 0 0 0 19600 0 20979 0 380611 0 0 0 BRUCE SACHAIS EXECUTIVE MEDICAL DIRECTOR 324696 0 24688 0 0 0 19600 0 32061 0 401045 0 0 0 BERNADETTE TISO DEPUTY GENERAL COUNSEL 225410 0 12400 0 0 0 16528 0 32852 0 287190 0 0 0 DAVID GRAHAM Executive Director - CBCKC 272045 0 19394 0 0 0 19600 0 31011 0 342050 0 0 0 DONNA STRAUSS VP - ENTERPRISE LAB SERVICE 292020 0 26000 0 0 0 28000 0 18555 0 364575 0 0 0 PATRICIA KILLEEN VP-ENT BLOOD OPS OPTIMIZATION 279931 0 26000 0 0 0 19600 0 23134 0 348665 0 0 0 MONIQUE BROWN GEORGE VP - HUMAN RESOURCES 212090 0 0 0 0 0 15635 0 13608 0 241333 0 0 0 Schedule J, Part I, Line 4a C. Elizabeth Gibson received a severance payment of $347,970. SCHEDULE J, PART I, LINE 4B THE INDIVIDUALS LISTED BELOW PARTICIPATED IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN. PAYMENTS WERE VESTED AND RECEIVED IN 2019 AND INCLUDABLE IN INCOME. - C. ELIZABETH GIBSON - $9,296 - BETH SHAZ - $16,450 - BETSY JETT - $5,950 - ELIZABETH MCQUAIL - $18,661 - Christopher Hillyer - $47,950 - JORDANA SCHWARTZ - $7,190 - ROBERT PURVIS - $3,500 SCHEDULE J, PART I, LINE 7 UPON THE ORGANIZATION ACHIEVING CERTAIN BUDGET THRESHOLDS, EXECUTIVES OTHER THAN THE CEO WERE ELIGIBLE FOR MERIT BONUSES OF UP TO 5% OR 10% OF THEIR ANNUAL BASE SALARIES, DETERMINED BY THEIR ACHIEVING PERFORMANCE BENCHMARKS ESTABLISHED BY SENIOR MANAGEMENT AND APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD. A RHODE ISLAND HEALTH AND EDUCATIONAL BUILDINGS CORP 521300173 000000000 2012-06-29 9000000 CONSTRUCTION OF AN ADDITION & REN false false false A 0 0 9000000 0 0 0 98450 0 0 8497647 403903 0 2014 false false true true A false false false false 0 false false false false A false false true false false false 0 false 0 false false A false SCHEDULE K, PART I, BOND ISSUES (A) ISSUER NAME: RHODE ISLAND HEALTH AND EDUCATIONAL BUILDING CORPORATION (F) DESCRIPTION OF PURPOSE: CONSTRUCTION OF AN ADDITION & RENOVATION OF FACILITIES. SCHEDULE K, PART I, BOND ISSUES PROCEEDS FROM THE BOND WERE TO BE USED TO FINANCE THE ACQUISITION, CONSTRUCTION, EQUIPPING AND FURNISHING OF A 20,000 SQUARE FOOT ADDITION ADJACENT TO THE MAIN FACILITY. THE ADDITION HOUSES THE ORGANIZATIONS OPERATIONAL REGULATORY FUNCTIONS, INCLUDING LABORATORIES AND DISTRIBUTION FUNCTIONS. IN ADDITION, RENOVATIONS AND IMPROVEMENTS WERE MADE TO THE ORGANIZATIONS MAIN FACILITY LOCATED AT 405 PROMENADE ST,PROVIDENCE, RI. SCHEDULE K, PART II, LINE 11 THE PROCEEDS FROM THE BOND ISSUE WERE PROVIDED IN THE FORM OF A DRAW DOWN FACILITY FROM WHICH PROCEEDS COULD BE DRAWN DOWN UNTIL MARCH 29, 2014. ALL AMOUNTS DRAWN WERE USED FOR CAPITAL EXPENDITURES AND BOND ISSUANCE COSTS IN THE AMOUNTS AS DESCRIBED ABOVE. ON MARCH 29, 2014, THE DRAW DOWN FACILITY CONVERTED TO A LOAN PAYABLE REQUIRING PRINCIPAL AND INTEREST PAYMENTS. AT THE CONVERSION DATE, THE TOTAL OUTSTANDING BORROWINGS AMOUNTED TO $8,596,097. A PREPAYMENT WAS MADE ON THE BOND FOR THE BALANCE OF THE BOND ISSUE, $403,903. MISSION STATEMENT PART I, LINE 1 AND PART III, LINE 1 AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NEW YORK BLOOD CENTER OPERATES UNDER A FOUR-PART MISSION. SPECIFICALLY, NYBC EXISTS: -TO PROVIDE THE HIGHEST QUALITY BLOOD AND STEM CELL PRODUCTS AND RELATED MEDICAL AND CONSULTATIVE SERVICES TO HOSPITALS AND PATIENTS. -TO CONDUCT THE HIGHEST QUALITY, NOVEL AND INNOVATIVE RESEARCH IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING AND TRANSFUSION MEDICINE, AND CELLULAR THERAPIES, THUS ADVANCING THESE FIELDS AND POSITIVELY IMPACTING THE PUBLIC HEALTH -TO DEVELOP PRODUCTS, TECHNOLOGIES, AND SERVICES IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING, AND TRANSFUSION MEDICINE AND CELLULAR THERAPIES, WITH THE POTENTIAL TO HAVE WORLDWIDE HUMANITARIAN IMPACT -TO TRAIN THE NEXT GENERATION OF LEADERS IN EACH OF THESE FIELDS GOVERNING BODY PART VI, SECTION A, LINE 1A THE BOARD MAY DESIGNATE STANDING COMMITTEES FROM AMONG ITS MEMBERS. THESE COMMITTEES INCLUDE AN EXECUTIVE COMMITTEE, COMPRISED OF A CHAIR, VICE CHAIR, AND AT LEAST THREE ADDITIONAL MEMBERS OF THE BOARD. THE EXECUTIVE COMMITTEE MAY EXERCISE BOARD POWERS IN BETWEEN MEETINGS OF THE BOARD. PART VI, SECTION A, LINE 4 BY-LAWS UPDATED TO STREAMLINE COMPOSITION, CLARIFY CERTAIN PRACTICES, AND PROMOTE GOOD GOVERNANCE. OFFICER, DIRECTOR, TRUSTEE, OR KEY EMPLOYEE BUSINESS RELATIONSHIP PART VI, SECTION A, LINE 2 The following individuals have a business relationship with one of the other individuals listed: CHRISTOPHER HILLYER, ELIZABETH MCQUAIL, JORDANA SCHWARTZ, BETH SHAZ, DAVID TENDLER, BERNADETTE TISO, AND MARK SCHMIDTLEIN. PROCESS OF FORM 990 REVIEW BY GOVERNING BODY PART VI, LINE 11A FOLLOWING COMPLETION OF THE FINANCIAL AUDIT, THE FORM 990 IS FINALIZED BY MANAGEMENT, REVIEWED BY AN INDEPENDENT ACCOUNTING FIRM, AND REVIEWED BY THE AUDIT COMMITTEE OF THE BOARD. THE FINAL FORM 990 IS THEN CIRCULATED TO THE FULL BOARD FOR REVIEW AND APPROVAL AT ITS ANNUAL MEETING. COMPLIANCE WITH CONFLICT OF INTEREST POLICY PART VI, LINE 12C AT THE BEGINNING OF EACH NEW FISCAL YEAR, AND ON AN AS-NEEDED BASIS, THE TAXPAYER REQUIRES ALL TRUSTEES, OFFICERS, KEY EMPLOYEES, AND SENIOR EXECUTIVES TO COMPLETE AND SIGN A STATEMENT DISCLOSING ANY ACTUAL OR APPARENT CONFLICT OF INTEREST. THESE STATEMENTS ARE REVIEWED BY THE AUDIT COMMITTEE OF THE BOARD, AS WELL AS BY THE CEO AND THE GENERAL COUNSEL. THE BOARD ULTIMATELY WILL DETERMINE WHETHER ANY CONFLICT OF INTEREST EXISTS AND, IF SO, IT APPOINTS A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE AND DETERMINE HOW TO MANAGE ANY SUCH CONFLICT. IN ADDITION, THE TAXPAYER MAINTAINS A GENERAL CONFLICT OF INTEREST POLICY THAT APPLIES TO ALL EMPLOYEES. PROCESSES FOR DETERMINING COMPENSATION PART VI, LINE 15 THE TAXPAYER'S PROCESS FOR DETERMINING COMPENSATION OF ITS CEO INCLUDED REVIEW AND APPROVAL BY THE INDEPENDENT COMPENSATION AND EXECUTIVE COMMITTEES OF THE BOARD AND BY THE FULL BOARD, AS WELL AS ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, AND FORMS 990 OF OTHER ORGANIZATIONS. ALL COMPENSATION REVIEW PROCESSES ARE CONTEMPORANEOUSLY DOCUMENTED. FOR DETERMINING COMPENSATION OF ITS OTHER OFFICERS AND ITS KEY EMPLOYEES, THE TAXPAYER USED ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, REVIEW BY THE CEO AND APPROVAL BY THE INDEPENDENT COMPENSATION COMMITTEE OF THE BOARD. PUBLIC AVAILABILITY OF INFORMATION PART VI, LINE 19 THE TAXPAYER MAKES ITS FINANCIAL STATEMENTS AVAILABLE UPON REQUEST, AND ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND CODE OF CONDUCT AVAILABLE BOTH UPON REQUEST AND ON ITS WEBSITE. OTHER CHANGES IN NET ASSETS PART XI, LINE 9 UNREALIZED GAIN/LOSS ON SWAP AGREEMENT $(159,472) STUB-PERIOD EARNINGS OF ACQUIRED SUBSIDIARIES $2,182,730 --------------------- TOTAL $2,023,257 COMMUNITY BLOOD CENTER OF GREATER KANSAS CITY ACQUISITION ON AUGUST 1, 2014, NYBC BECAME THE SOLE MEMBER OF COMMUNITY BLOOD CENTER OF KANSAS CITY (CBC), A SECTION 501(C)(3) EXEMPT ORGANIZATION WHOSE EXEMPT PURPOSE IS TO COLLECT, PROCESS, TEST, STORE, AND DISTRIBUTE HUMAN BLOOD IN THE GREATER KANSAS CITY, MO AREA. NO CASH CONSIDERATION WAS EXCHANGED AT THE CLOSING OF THE ACQUISITION OF CBC BUT NYBC HAS RECOGNIZED ITS INTEREST IN CBC BY APPLYING THE ACQUISITION METHOD OF ACCOUNTING. EFFECTIVE APRIL 1, 2018, CBC BECAME AN OPERATING DIVISION OF NYBC. Innovative Blood Resources acquisition on August 1, 2017, NYBC became the sole member of Innovative Blood Resources (IBR), a section 501( c)(3) exempt organization whose exempt purpose is to collect, process, test and distribute human blood in St. Paul, Duluth, Minnesota, and Lincoln, Nebraska. No cash consideration was exchanged at the closing of the acquisition of IBR but NYBC has recognized its interest in IBR by applying the acquisition method of accounting. Effective January 1, 2020, IBR became an operating division of NYBC. Blood Bank of Delmarva Acquisition On August 1, 2017 (the Acquisition Date), NYBC closed on the acquisition Blood Bank of Delmarva (BBD) by becoming the sole corporate member of BBD (the Transaction). BBD is a general not for profit corporation, organized to serve the community by meeting the needs of patients, hospitals and members for safe, high quality blood products and related services for the 13 county area encompassing the Delmarva Peninsula and beyond. No cash consideration was exchanged at the closing of the Transaction. NYBC ACCOUNTED FOR THIS BUSINESS COMBINATION BY APPLING THE ACQUISITION METHOD. Effective October 1, 2019, BBD became an operating division of NYBC. Rhode Island Blood Center Acquisition On July 1, 2017 (the Acquisition Date), NYBC closed on the acquisition Rhode Island Blood Center (RIBC) by becoming the sole corporate member of RIBC (the Transaction). RIBC is a State of Rhode Island and Providence Plantations general not for profit corporation, organized for the purpose of collecting and distributing human blood and blood products for the hospitals of Rhode Island while also serving customers in various states. No cash consideration was exchanged at the closing of the Transaction. NYBC accounted for this business combination by applying the acquisition method. Effective May 1, 2019, RIBC became an operating division of NYBC. INNOVATIVE BLOOD RESOURCES 737 PELHAM BLVD ST PAUL MN 55114 410693869 BLOOD CENTER MN 501(C)(3) 10 NY BLOOD CTR true RHODE ISLAND BLOOD CENTER 405 PROMENADE STREET PROVIDENCE RI 02908 050317817 BLOOD CENTER RI 501(C)(3) 10 NY BLOOD CTR true BLOOD BANK OF DELMARVA 100 HYGEIA DRIVE NEWARK DE 19713 510078596 BLOOD CENTER DE 501(C)(3) 10 NY BLOOD CTR true false false false false false false true true false false false true false false false false false false false INNOVATIVE BLOOD RESOURCES g 151538 FMV CASH PAID INNOVATIVE BLOOD RESOURCES h 4948084 FMV CASH PAID INNOVATIVE BLOOD RESOURCES l 900000 FMV CASH PAID RHODE ISLAND BLOOD CENTER l 225000 FMV CASH PAID RHODE ISLAND BLOOD CENTER g 443183 FMV CASH PAID RHODE ISLAND BLOOD CENTER h 1377107 FMV CASH PAID BLOOD BANK OF DELMARVA l 300000 FMV CASH PAID BLOOD BANK OF DELMARVA g 149899 FMV CASH PAID BLOOD BANK OF DELMARVA h 819723 FMV CASH PAID